NDC 13533-635

GAMASTAN

Immune Globulin (human)

GAMASTAN is a Intramuscular Injection, Solution in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is Human Immunoglobulin G.

Product ID13533-635_38a323af-7c25-42d1-9c29-532ef61999b8
NDC13533-635
Product TypePlasma Derivative
Proprietary NameGAMASTAN
Generic NameImmune Globulin (human)
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR
Marketing Start Date1996-08-14
Marketing CategoryBLA / BLA
Application NumberBLA101134
Labeler NameGRIFOLS USA, LLC
Substance NameHUMAN IMMUNOGLOBULIN G
Active Ingredient Strength0 g/mL
Pharm ClassesAntigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 13533-635-04

1 VIAL in 1 CARTON (13533-635-04) > 2 mL in 1 VIAL (13533-635-40)
Marketing Start Date1996-08-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13533-635-12 [13533063512]

GAMASTAN INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA101134
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1996-08-14

NDC 13533-635-40 [13533063540]

GAMASTAN INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA101134
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-11-16

NDC 13533-635-10 [13533063510]

GAMASTAN INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA101134
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1996-08-14
Marketing End Date2018-06-27

NDC 13533-635-04 [13533063504]

GAMASTAN INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA101134
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1996-08-14

NDC 13533-635-02 [13533063502]

GAMASTAN INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA101134
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1996-08-14
Marketing End Date2018-06-27

NDC 13533-635-13 [13533063513]

GAMASTAN INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA101134
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-11-16

Drug Details

Active Ingredients

IngredientStrength
HUMAN IMMUNOGLOBULIN G.165 g/mL

Pharmacological Class

  • Human Immunoglobulin G [EPC]
  • Passively Acquired Immunity [PE]
  • Antigen Neutralization [MoA]
  • Immunoglobulins [CS]

NDC Crossover Matching brand name "GAMASTAN" or generic name "Immune Globulin (human)"

NDCBrand NameGeneric Name
13533-335GamaSTANimmune globulin (human)
13533-635GAMASTANIMMUNE GLOBULIN (HUMAN)
61953-0004FlebogammaImmune Globulin (Human)
76125-900GAMMAKEDImmune Globulin (Human)
13533-800Gamunex-CImmune Globulin (Human)

Trademark Results [GAMASTAN]

Mark Image

Registration | Serial
Company
Trademark
Application Date
GAMASTAN
GAMASTAN
78627286 3199710 Live/Registered
GRIFOLS THERAPEUTICS LLC
2005-05-11
GAMASTAN
GAMASTAN
72183886 0784730 Dead/Expired
CUTTER LABORATORIES, INC.
1964-01-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.